Literature DB >> 24508576

Using the reversible inhibition of gastric lipase by Orlistat for investigating simultaneously lipase adsorption and substrate hydrolysis at the lipid-water interface.

Anaïs Bénarouche1, Vanessa Point1, Frédéric Carrière2, Jean-François Cavalier3.   

Abstract

The lipolysis reaction carried out by lipases at the water-lipid interface is a complex process including enzyme conformational changes, adsorption/desorption equilibrium and substrate hydrolysis. Mixed monomolecular films of the lipase inhibitor Orlistat and 1,2-dicaprin were used here to investigate the adsorption of dog gastric lipase (DGL) followed by the hydrolysis of 1,2-dicaprin. The combined study of these two essential catalysis steps was made possible thanks to the highest affinity of DGL for Orlistat than 1,2-dicaprin and the fact that the inhibition of DGL by Orlistat is reversible. Upon DGL binding to mixed 1,2-dicaprin/Orlistat monolayers, an increase in surface pressure reflecting lipase adsorption was first recorded. Limited amounts of Orlistat allowed to maintain DGL inactive on 1,2-dicaprin during a period of time that was sufficient to determine DGL adsorption and desorption rate constants. A decrease in surface pressure reflecting 1,2-dicaprin hydrolysis and product desorption was observed after the slow hydrolysis of the covalent DGL-Orlistat complex was complete. The rate of 1,2-dicaprin hydrolysis was recorded using the surface barostat technique. Based on a kinetic model describing the inhibition by Orlistat and the activity of DGL on a mixed 1,2-dicaprin/Orlistat monolayer spread at the air-water interface combined with surface pressure measurements, it was possible to monitor DGL adsorption at the lipid-water interface and substrate hydrolysis in the course of a single experiment. This allowed to assess the kcat/KM* ratio for DGL acting on 1,2-dicaprin monolayer, after showing that mixed monolayers containing a low fraction of Orlistat were similar to pure 1,2-dicaprin monolayers.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Enzyme kinetics; Interfacial enzymology; Lipase; Lipase inhibition; Lipolysis; Monomolecular film

Mesh:

Substances:

Year:  2014        PMID: 24508576     DOI: 10.1016/j.biochi.2014.01.019

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

Review 1.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

2.  Novel Natural Oximes and Oxime Esters with a Vibralactone Backbone from the Basidiomycete Boreostereum vibrans.

Authors:  He-Ping Chen; Zhen-Zhu Zhao; Zheng-Hui Li; Ze-Jun Dong; Kun Wei; Xue Bai; Ling Zhang; Chun-Nan Wen; Tao Feng; Ji-Kai Liu
Journal:  ChemistryOpen       Date:  2016-01-13       Impact factor: 2.911

3.  Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity.

Authors:  Ulf Holmbäck; Anders Forslund; Stefan Grudén; Göran Alderborn; Arvid Söderhäll; Per M Hellström; Hans Lennernäs
Journal:  Obes Sci Pract       Date:  2020-02-07

4.  Discovery and characterization of a small-molecule enteropeptidase inhibitor, SCO-792.

Authors:  Masako Sasaki; Ikuo Miyahisa; Sachiko Itono; Hiroaki Yashiro; Hideyuki Hiyoshi; Kazue Tsuchimori; Ken-Ichi Hamagami; Yusuke Moritoh; Masanori Watanabe; Kimio Tohyama; Minoru Sasaki; Jun-Ichi Sakamoto; Tomohiro Kawamoto
Journal:  Pharmacol Res Perspect       Date:  2019-09-04

Review 5.  Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis.

Authors:  Giovanni Stelitano; José Camilla Sammartino; Laurent Roberto Chiarelli
Journal:  Molecules       Date:  2020-03-09       Impact factor: 4.411

6.  The Influence of Fed State Lipolysis Inhibition on the Intraluminal Behaviour and Absorption of Fenofibrate from a Lipid-Based Formulation.

Authors:  Marlies Braeckmans; Joachim Brouwers; Danny Riethorst; Cécile Servais; Jan Tack; Patrick Augustijns
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.